Array BioPharma Inc.
Array BioPharma Inc. is named on 0 US grants and 10 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 0
- Published applications
- 10
- Inventors
- 59
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 3 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
By publication year.
Technology areas
Share of 10 documents
- A61PTherapeutic uses of medicines9
- C07DHeterocyclic compounds8
- A61KMedicines and medical preparations3
- C07CAcyclic or carbocyclic compounds2
- C07KPeptides2
- G01NInvestigating or analysing materials by determining their chemical or physical properties1
- G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or1
- Y02ATechnologies for adaptation to climate change1
Recent patents
No granted patents yet.
- Kras g12c inhibitors16 May 2019US 2019/0144444 A1
- Kras g12c inhibitors28 Feb 2019US 2019/0062330 A1
- Pyrimidyl cyclopentanes as akt protein kinase inhibitors30 Jun 2011US 2011/0160221 A1
- Imidazo [4,5-b] pyridine derivatives used as raf inhibitors6 Jan 2011US 2011/0003809 A1
- P38 inhibitors and methods of use thereof23 Nov 2006US 2006/0264431 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.